Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Orgenesis (45O0) Stock Price & Analysis

45O0 Stock Chart & Stats

€3.60€0.00(0.00%)
At close: 5:30 PM GMT+1
EUR 5EUR 6EUR 7EUR 819 Mar4 Apr10 Apr
Day’s Range
EUR 3.60 - EUR 3.92
52-Week Range
EUR 3.60 - EUR 3.92
Previous Close
EUR 3.60
Volume
0
Average Volume (3M)
0
Market Cap
EUR 245.30K
Enterprise Value
EUR 37.17M
Total Cash (Recent Filing)
EUR 204.00K
Total Debt (Recent Filing)
EUR 17.30M
Price to Earnings (P/E)
―
Beta
N/A
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Business Model Innovation

The POCare platform represents a strategic shift towards decentralized therapy production, potentially reducing costs and improving patient access, which can enhance long-term market positioning and competitiveness.

Strategic Partnerships

Strategic partnerships and licensing agreements expand Orgenesis' market reach and revenue potential, fostering sustainable growth and innovation in the biotech sector.

Corporate Governance

Enhancements in corporate governance through board expansion may lead to better strategic oversight and operational improvements, supporting long-term organizational stability and growth.

Bears Say

Financial Instability

Negative equity and financial instability indicate a leveraged position, posing risks to financial health and necessitating urgent strategic realignment or external support.

Liquidity Issues

Negative cash flows highlight liquidity constraints, limiting the company's ability to fund operations and invest in growth, potentially affecting long-term viability.

Revenue Decline

Declining revenue and negative profit margins suggest operational inefficiencies, threatening growth prospects and necessitating strategic interventions to reverse trends.

Orgenesis News

45O0 FAQ

What was Orgenesis’s price range in the past 12 months?
Orgenesis lowest stock price was €3.60 and its highest was €3.92 in the past 12 months.
What is Orgenesis’s market cap?
Orgenesis’s market cap is €245.30K.
When is Orgenesis’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Orgenesis’s earnings last quarter?
Orgenesis released its earnings results on Nov 13, 2024. The company reported -€1.722 earnings per share for the quarter.
Is Orgenesis overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Orgenesis pay dividends?
Orgenesis does not currently pay dividends.
What is Orgenesis’s EPS estimate?
Orgenesis’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Orgenesis have?
Orgenesis has 9,799,538 shares outstanding.
What happened to Orgenesis’s price movement after its last earnings report?
Orgenesis reported an EPS of -€1.722 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Orgenesis?
Currently, no hedge funds are holding shares in DE:45O0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology